Abacus Global Management, Inc. (ABX) Earnings Call Transcript & Summary

August 14, 2023

New York Stock Exchange US Financials Insurance earnings

Earnings Call Speaker Segments

Garrett Edson

executive
#1

Hello everyone, and thanks for joining us today. We appreciate your time. Abacus Life directs those on this call to the investor page at www.abacuslife.com/investors, where you can find the press release, investor materials, and SEC filings covering a discussion of risks that may impact the business. Abacus Life also points listeners specifically to the presentation filed today with the SEC on Form 8-K, to remind everyone that certain remarks made today might include forward-looking statements, and therefore will carry risks and uncertainties that, should they occur, could significantly affect results. Forward-looking statements encompass, though are not restricted to, Abacus Life's expectations or forecasts regarding financial and business performance and conditions, along with its competitive and industry outlook. Forward-looking statements carry risks, uncertainties, and assumptions that, if realized, could significantly affect results, and these forward-looking statements do not promise performance, and Abacus Life provides such assurances. Abacus Life has no obligation and explicitly disclaims any duty to update, change, or otherwise amend any forward-looking statements, whether due to new information, future events, or anything else, unless the law requires it. Furthermore, historical data relating to operating results and other performance indicators relevant to Abacus Life are not necessarily a sign of results to be attained in later periods. I'll now hand the call over to Jay Jackson, Chief Executive Officer of Abacus Life.

Jay Jackson

executive
#2

I want to thank each of you for tuning in today and for the interest you've shown in Abacus. This marks our inaugural earnings call since becoming a publicly traded company, and we're glad to have you here. Joining me is Bill McCauley, who serves as our Chief Financial Officer. Once we finish our prepared comments, we'll turn things over to you for questions. The robust results we delivered in the second quarter offer further proof that Abacus's distinctive business model works, and they add to the lengthy record we've established of growing both sustainably and profitably. Beyond the progress we keep making, we're thrilled that we wrapped up our public listing successfully after the quarter closed — a significant achievement for our ambitions to grow over the long haul. With our demonstrated business model, skilled team, abundant data, and cutting-edge technology, we're positioned favorably to carry out our strategic plans, seize the numerous promising opportunities in front of us, and in the end build lasting value for those who hold our shares. Because this is the first time we're speaking to you as a public company, and since some of you might be learning about our story for the first time, I'd like to take a few minutes to explain our compelling business model, the value we offer, and the reasons we're so enthusiastic about the chances we see to expand our business profitably and sustainably while delivering shareholder value over the long term. Across the past 19 years, we've assembled a vertically integrated company that both manages alternative assets and originates them, with a focus on insurance products, financial management, and technology. Within this space, we hold a leading position, commanding substantial market share in a market that's difficult for newcomers to enter, and we're led by a seasoned, capable management team whose members each bring more than 20 years of experience. Importantly, Abacus is already producing strong, expanding revenue within a $13 trillion market, has achieved GAAP profitability for 19 straight years, and enjoys highly attractive margins. Put simply, our main business involves assisting clients in recognizing that a life insurance policy constitutes personal property, and that selling one at fair market value represents a legitimate, safe, and workable option, which enables them to unlock additional financial choices going forward. For many senior citizens, life insurance represents their biggest asset — one that could ease the difficulties of retirement — yet they seldom view it in those terms. Rather than treating it as equity, most individuals treat their life insurance as though it were debt; it sits on the incorrect side of their ledger. We help clients change that way of thinking so they can generate value and optionality for themselves; we compete in an enormous and largely untapped addressable market exceeding $200 billion each year, which gives us exceptional potential for long-term growth. If there's a single point you remember from what we've said today, let it be this: life insurance ranks among the biggest markets worldwide, totaling $13 trillion within the United States by itself; that amounts to two and a half times the size of America's residential real estate market, and in that market, more than nine out of 10 life insurance policies — 90% — will never result in a claim being paid. Our product is highly favored by institutional investors, since it's an asset with low correlation to other assets, and we additionally benefit from very strong institutional counterparties with investment-grade ratings. Abacus occupies a central position within the life settlement sector, and the extremely effective way we originate business powers everything about our financial model, something we think translates into above-market expansion opportunities for both Abacus and its stockholders. After we pinpoint policies that might be worth acquiring, they eventually pass through that origination engine of ours, and we provide a range of products aimed at fueling revenue growth. One option is selling those policies straight to our capital partners, recording gains along the way. Another is putting them into inventory so we can trade the asset in a strategic manner. To put a figure on it, we have traded in excess of $1 billion across the past three years. A third path is keeping the asset on our balance sheet, leveraging our asset management portfolio alongside our servicing platform to merely handle the assets still held on our books. Beyond that, we are able to construct separately managed accounts on behalf of third-party investors and institutions, or acquire the policies inside our investment funds; within this product line, we have brought in more than $40 million of fresh capital during the past six months and expect to add further funds to it in the year ahead. In addition to our origination and asset management platforms, we possess a proprietary risk technology platform that assists us in evaluating the risk tied to these life insurance contracts and managing them, enabling us to assemble portfolio tranches and build out the balance sheet rapidly, which delivers extra liquidity via our active portfolio management. Now let's discuss the counterparty. The counterparties on our policies tend to be high-quality, investment-grade insurance companies. Ordinarily, 95% of all carriers held in our portfolio carry a rating of A or better from AM Best. The underlying credit they issue is the life insurance policy, and it ranks within the cash stack above any senior debt or equity they issue. On top of that, this product faces heavy regulation at the point of inflection. As a matter of fact, we know of no single life insurance policy ever issued that failed to pay at mortality because of carrier illiquidity. Consequently, the asset itself is remarkably stable. The genuine pain point we believe we are addressing is that investors are unable to locate a sufficient number of life insurance policies to buy. Besides counterparty quality, this asset class displays a low correlation with the overall market. What does that mean exactly? It amounts effectively to a mortality-driven zero coupon bond. Its value will rise as the maturity date draws nearer, no matter what happens with equity or bond market conditions or volatility. To put it simply, imagine we purchase a contract on a male aged 80. After three years, that gentleman reaches 83, meaning the contract has moved that much closer to its ultimate maturity date, and you get an increase in the value of the underlying contract as the insured person ages. So it is not just an excellent counterparty — the contract also gains value over time, no matter what market conditions do. More than 30,000 financial professionals have joined forces with Abacus, and most of the policies we originate still come through that partnership network. That said, the channel growing faster than any other is the one where we sell straight to consumers. This channel has us genuinely thrilled, and so does the long-term growth potential it brings. We've spent several years developing it. The beauty of going direct to consumers is that we can connect with policy owners ourselves and teach them about their own liquidity options. To keep growing our market share and raise awareness across the industry, we plan to keep running our television and digital campaigns. Beyond the marketing efforts that fuel our top line, what truly serves as our foundational asset is the extensive technology we've created and the longevity data gathered across the years. Grounded in aggregated data and analytics built up over time, Abacus also functions as a data technology firm, applying its proprietary information to guide how we decide which policies to acquire, and drawing on it to support various other products and processes; within our own sector, we've pioneered technology by developing our own underlying insurance and data tables, which help us invest more wisely, bring new insurance products to market, and move the wealth planning field forward; our longevity data and technology, overseen by our subsidiary Longevity Market Technologies, can, we believe, make a positive difference across multiple industries.

Jay Jackson

executive
#3

To start, let me talk about our digital origination platform, which we call the Abacus Marketplace. Through it, advisors along with their clients can complete a fully digital, end-to-end purchase of a life insurance policy. We also anticipate bringing innovation to the way life insurance gets issued and underwritten when a policy is issued. Right now we're moving forward on a partnership with a life insurance carrier aimed at issuing new products based on lifespan. Beyond that, we plan to roll out innovative investment portfolio allocations for retail investors that draw on their personal lifespan, which gets calculated through agingiq.com, our top online life expectancy calculator featuring selfie and facial analytics technology. That would let investors rely on their own lifespan as the main driver behind portfolio allocation. On the process side, we've put substantial investment into understanding risk better and figuring out how to measure it properly and swiftly on these contracts. We've created our proprietary risk rating platform, which gauges risk in a way that's comparable to a risk-related FICO score. Several factors feed into this risk score, among them duration and extension risk, which we assess relative to the future carry costs of the contract. Leveraging our extensive data, we analyze the underlying contract so we can rapidly determine where that contract stands and, in the end, power Abacus' purchase and valuation process. In addition, we rely on our proprietary data analytics to boost origination and awareness by building something we refer to as our instant policy value calculator. It's a simple online tool requiring just four data points — gender, age, face value, and policy type — to produce an immediate indicative policy valuation that we hand to advisors and consumers, letting them quickly see what their policy is currently worth. By providing this data and educating consumers, we'll help close the gap on the $233 billion in life insurance policies that lapse each year. In our view, the life settlement market will keep growing, supported by a major tailwind from efforts to teach clients about what their policies are worth. Today our industry has only around 2% market penetration of a $200 billion+ opportunity, and there's a hefty financial incentive for seniors who sell their policy; that leaves a huge gap, and it's squarely in our wheelhouse. We're confident we can close that gap, since Abacus sits at the heart of this industry. Our financial metrics demonstrate this benefit. We've delivered consistent growth year-over-year, particularly in origination capital deployment, net earnings, and return on equity; that carried into 2023, and since we once again delivered on growth and profitability in the second quarter, which Bill will get to in a moment, we've gone back over our historical trends. We've carefully assessed expected origination growth, examined our revenue streams and the matching expenses to run this business, and prudently applied that to our public company. With that, I'll hand things over to our CFO, Bill McCauley, to walk through the specifics on our Q2 results and financials.

Bill McCauley

executive
#4

Thank you, Jay, and good morning to all of you. Like Jay said, we turned in yet another robust quarter, with expansion and profitability seen throughout our operations. Although we had not yet become a public company and had not merged into the entity we now operate as during the second quarter, I'll go over those second quarter results on a pro forma basis as though we had, since that gives you the cleanest like-for-like view going forward. The primary force behind how our business performed is the extremely efficient platform we use for origination; during the second quarter of 2023, the capital we put to work in originations rose by about 88%, reaching $59.7 million, up from $31.9 million in the comparable earlier period, fueled by acquisitions of policies with bigger face values, all while keeping policy originations growing at 4%, reaching 141 versus 135 in the same period a year earlier. Total revenue for the second quarter of 2023 climbed 30%, hitting $18.3 million, up from $14.1 million in the comparable earlier period. That gain came mainly from robust results in our Active Management segment, since we allocated additional capital to fuel expansion and originations. Revenue in Active Management rose by roughly 38%, reaching $11 million, up from $8 million in the same period a year earlier. This rise was mostly the result of maturities among policies handled under the investment method. As of June 30th, 2023, Abacus holds 167 policies, and of that total, 121 fall under the fair value method, while 46 are handled through the investment method, meaning cost plus premiums paid. Policies carried under the investment method are those Abacus bought intending to sell them within the coming 12 months. Revenue from our Portfolio Servicing segment came to $0.4 million, which is about the same as the comparable earlier period. Moving to expenses, total operating expenses, once you exclude unrealized gains and losses along with change in fair value for the second quarter of 2023, came to roughly $4.3 million, versus $4.6 million in the comparable earlier period. Adjusted EBITDA for the quarter rose by about 33%, reaching $8.8 million, versus $6.6 million in the comparable earlier period. This gain stemmed mainly from the robust growth in revenue. Adjusted EBITDA margin rose 140 basis points, reaching 48.4% for the quarter, versus 47% in the comparable earlier period. Net income climbed by roughly 40%, reaching $6.4 million, versus $4.6 million in the comparable earlier period, fueled by robust top-line results and efficient cost management. Now let's shift our attention to the metrics on our balance sheet. On an annualized basis, return on equity and return on invested capital for the three-month period ended June 30, 2023, came in at 16% and 28.5%, respectively, which speaks to how profitable our business model is. As of June 30, 2023, the company held cash and cash equivalents of $20.6 million, balance sheet policy assets of $66.5 million, and outstanding long-term debt at fair value of $66.2 million; in short, we feel great about the robust results we posted this quarter, and we keep delivering double-digit growth on bottom — on both the top and bottom lines. Even though we aren't giving specific guidance right now, the growth opportunities in front of us have us enthusiastic, and our position is very strong for carrying out our long-term plans. Just so you know, in the next few days we'll be putting out our 2022 quarterly income statement figures so you can take a look. At this point I'll hand things back to Jay Jackson, our CEO, for the closing remarks.

Jay Jackson

executive
#5

Appreciate that, Bill. In closing, we feel Abacus Life sits in an exceptionally strong spot to seize a huge opportunity in a market that's changing quickly right now. Hardly any other business models can point to 19 years of consecutive net income, plus a $200 billion addressable market that, in our view, will grow annually across new expansion verticals, with our longevity data and technology leading the way. Being a growth company that has delivered steady profitability makes us proud, and we anticipate keeping that up for the long haul, generating shareholder value along the way. Thanks to each of you for being with us today — we're grateful for your interest in Abacus Life, and at this point we'll take whatever questions you have.

Jim Morrow

executive
#6

Sure, thank you. Jay, would you be able to expand a bit further regarding those figures you mentioned, and the way they factor into this sector, plus how the information you're gathering can be leveraged as time goes on?

Jay Jackson

executive
#7

Absolutely. Thanks, Jim. If data truly represents the modern gold rush, then we are positioned atop quite a substantial pile of it. Here's the background: for 19 years, we have gathered information tied to medical records and lifespan figures for each policyholder whose policies we purchase. At this point, we've reached a stage where we can explore ways to apply that information not just to streamline what we do, but—more crucially—to deliver real value to the consumer. In other words, if our operations become more efficient and we can hand that information back to them, what additional purposes might it serve? Take this brief illustration: we created a tool named Med Scout. When we obtain medical records—possibly from multiple doctors, running several hundred pages—Med Scout rearranges the whole file, orders it by date alongside the corresponding physicians, then applies AI to extract everything, examine and interpret the content, and finally produce a probability of diagnosis together with ICD codes for that individual. Within our existing operations, the benefit shows up like this: we can now complete underwriting on a case in just minutes, whereas a person would otherwise spend hours reading and sorting through it. So then you look at that information and ask, "Alright, how might this be used in, say, healthcare, leveraging this kind of rapid information access?" Picture a doctor in an emergency room—she could diagnose a patient swiftly, select the straightforward link for that diagnosis (the probability of diagnosis), and instantly locate within 500 pages of medical records where that diagnosis appears, the number of occurrences, and how severe it is. After that, we draw on the lifespan figures—since we collect the medical records and translate them into a revised projected lifespan for the individual—and carry that into personal finance, an area where we will launch something very soon, showing how lifespan factors into financial planning. This centers particularly on transforming the way target date funds operate now, so that every individual might have a target date fund of their own, built around their lifespan and their data. As we first applied the data to strengthen our existing offerings, and continuing right up to the present, our upcoming initiative will target the enormous life tracking sector. We perform that tracking for insurers and policyholders after we buy and hold the policy, relying on Med Scout to improve underwriting comprehension and to rapidly reach someone's underwriting details; this could serve life insurance companies as well as the healthcare field. And finally, when it comes to financial services — something we'll get into in a moment — think about tailoring an individual's financial plan around how long they're expected to live; that information is going to feed into various verticals, but even more crucially, it will strengthen what is right now our central business: getting an even sharper read on, and better underwriting of, the people we insure ourselves.

Jim Morrow

executive
#8

That's great. Thanks, Jay.

David Bastian

analyst
#9

Hi, everyone. I appreciate you letting me ask something. I wanted to know whether you could weigh in on how much rates have climbed lately, and how you manage to remain profitable even though I'd expect the discounted future cash flows tied to your policies to drop quite a bit.

Jay Jackson

executive
#10

Of course. I'm glad you brought that up. Our sector, as an investment, basically has no correlation to the broader markets, because what drives it is mortality, and it isn't swayed by what happens with fixed income or equities. That said, the place where rates really do have an effect on us relates to what our own capital costs, which is exactly why we chose to become a public company — it helps us offset part of that exposure. Going public allows us, over time, to bring down our cost of capital, which lets us handle it better. Here's what we're seeing right now. I'd say this matters enormously to what we do. We truly occupy the center of our industry. What does that mean in practice? In effect, we act as the market makers, and each month we write new contracts amounting to somewhere between $15 million and $20 million in fresh capital available for us to put to work. You could see that in what we reported for the second quarter. When we point to an 88% rise in capital deployed, that's the quarter-over-quarter figure we recorded. As we see it, when rates are elevated, we actually land in something of a favorable position. The reason is this: in conditions like these, policyholders want liquidity, and they're now approaching us with the realization that their life insurance policy works as a viable liquid choice — something they might not have recognized previously — so our originations rise. On top of that, since we function as an alternative asset manager inside our own portfolio, and given that this asset is essentially uncorrelated, there's a great deal of institutional money seeking exposure to it in pursuit of double-digit discount rates and returns, even with rates where they are now, because the asset underneath carries no correlation. Looking at it through the lens of interest rates and market volatility, the position Abacus holds as market maker is genuinely a favorable one, and I believe our second quarter bears that out. That shows up when you examine the earnings growth, the net income growth, and the growth in originations.

David Bastian

analyst
#11

Understood, that's quite useful. Thanks. So, on a similar note, there are these warrants outstanding. Do you consider them a funding avenue you want to see exercised, or do you expect to rely on the provisions within them to effectively trigger a cashless exercise and eliminate them ahead of when they lapse in a few years?

Jay Jackson

executive
#12

Yes, both paths work for us. Our thinking was that we should hold a few earnings calls and let everyone get really at ease with how our business operates. Above all, this is about teaching people who Abacus is, what we do, and helping them grasp the data we hold and the way we deploy it across life insurance and beyond. After that, figure out which approach to the warrants serves us best. Either one suits us. If the warrants end up in the money and that benefits the shareholders who remained with us throughout, wonderful. Should there be an approach that makes sense whereby we would deliberately buy those back or acquire them and take them off the balance sheet, we would definitely weigh that too. We're, well. Beyond the warrants, we're also watching the float extremely carefully, and we recognize that this is the problem for anyone who lists through a SPAC: your float may be on the smaller side. With the same logic as the warrants, we're contemplating when, and, and, and how a secondary offering might work for us in the near term. For us, it simply comes down to first distributing our information, making investors really at ease with our story, and then looking into every one of those choices sooner rather than later.

David Bastian

analyst
#13

All right. Considering how big the market is, do you think that if the warrants brought in more than $150 million, you could put that money to work fast? What sort of timeline would you anticipate, considering how much of.

Jay Jackson

executive
#14

Certainly

David Bastian

analyst
#15

would that boost the amount of capital you have available?

Jay Jackson

executive
#16

Yes, that's an excellent question, and yes is the answer — we could put that to work extremely fast. Once more, consider the capital we originated and deployed during Q2 alone — bear in mind that came from our own funds, correct? Think about what an extra $100 million or $150 million would let us do. Looking at that figure alone, it suggests we were putting out roughly $20 million each month across the second quarter. So you can take that math further — if we held that speed, which I believe we'd likely push higher, even keeping that pace means getting it all out in under six months. What you're pointing to matters enormously and everyone ought to grasp it. What are we using those funds for? Buying this asset, correct? We aren't sitting here attempting to bring on additional staff, to pursue those sorts of things, or to pour money into some growth model that generates no revenue or income. That money goes straight back into the asset we're acquiring and onto our balance sheet, correct? In effect, owning policies. That ought to sound wonderful to you — the way we put that capital to work, its purpose, which would in the end, in the end, drive expansion of our business and company, lift revenues, lift income.

David Bastian

analyst
#17

Yes, that's clear. Thanks very much.

Jay Jackson

executive
#18

Alright, I want to thank everybody once more for spending time with us on this call today. It's exciting for us to keep telling our story — a story featuring 19 straight years of positive net income, outstanding ROIC, strong ROE — and we're a growth company sitting in front of a huge addressable market that we've only started to reach, backed by data and technology that lets us move into those additional verticals you'll begin seeing within the next six months. We'll keep making this story simpler and simpler for you and your investors to follow. As investors and shareholders, we appreciate your coming along on this journey with us. We're very excited about the second quarter results, and we look forward to future earnings calls with all of you.

Operator

operator
#19

Everyone, that brings today's teleconference to a close. At this point you're free to drop off the lines. We appreciate you joining us, and enjoy the rest of your day.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Abacus Global Management, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

For developers and AI pipelines

Programmatic access to Abacus Global Management, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Abacus Global Management, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.